Keep at it, eventually there will be a turn around
960_ 2/2/11 - ARCA Biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. Larry interviewed Michael R. Bristow, MD, Ph.D. CEO & Chief Science and Medical Officer of ARCA at the CU Technology Transfer Office Awards banquet. Dr. Bristow has been a favorite interview for w3w3® for years. Larry asked him, "Michael what are the biggest changes you've seen in this last year in your industry?" He replied, "It's been a couple of tough years, but I think things are starting to turn around and basically the atmospherics have gotten a lot better. Just coming off a JP Morgan meeting, it was, I thought, a completely different tone this year." Dr. Bristow had some interesting insights about funding. "Well, it's sort of like financing of real estate was back in the early 80s when interest rates were 20% - you've got to do creative financing. So, all kinds of vehicles have been used through this period. ARCA biopharma, for instance did a reverse merger, bought a company that was NASDAQ listed, that had a bunch of cash - that proved to be a good move. So people have gotten through this one way or another. But we need to get back to traditional sources of funding." Larry asked, "Is there any particular advice to people in your arena?" Spoken like a true leader he replied, "Yes, don't give up. I mean, tenacity, keep at it, eventually there will be a turn around. Now, when things aren't going too well, may be the best opportunity there is in terms of acquiring assets. Think ahead. Think positive." Dr. Bristow joined ARCA as one of ARCA’s founders in September 2004, and has served as Chairman and Chief Science and Medical Officer of ARCA until he was appointed to his current position of Chief Executive Officer in July 2009. Dr. Bristow is a Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, where he has been since October 1991. Dr. Bristow was one of the founders of Myogen, Inc.
Related Links: ARCA biopharma || CU Technology Transfer Office || CU TTO Channel || TTO Blog || CU TTO Awards || Award Photos || Keywords: Michael Bristow, ARCA biopharma, CU Technology Transfer Office, Biotech, Cardiology at the University of Colorado Health Sciences Center, University of Colorado Cardiovascular Institute 2/2/11 bytes=2927702
LISTEN to Michael R. Bristow, MD, Ph.D. CEO & Chief Science and Medical Officer of ARCA
Powered by Podbean.com